Cargando…

Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway

Angiogenesis is crucial for cancer initiation, development and metastasis. Identifying natural botanicals targeting angiogenesis has been paid much attention for drug discovery in recent years, with the advantage of increased safety. Isoliquiritigenin (ISL) is a dietary chalcone-type flavonoid with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhiyu, Wang, Neng, Han, Shouwei, Wang, Dongmei, Mo, Suilin, Yu, Linzhong, Huang, Hui, Tsui, Kamchuen, Shen, Jiangang, Chen, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702614/ https://www.ncbi.nlm.nih.gov/pubmed/23861918 http://dx.doi.org/10.1371/journal.pone.0068566

Ejemplares similares

Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation
por: Wang, Neng, et al.
Publicado: (2015)

Natural dietary compound naringin inhibits glioblastoma cancer neoangiogenesis
por: Aroui, Sonia, et al.
Publicado: (2020)

Bioactivity-Guided Identification and Cell Signaling Technology to Delineate the Lactate Dehydrogenase A Inhibition Effects of Spatholobus suberectus on Breast Cancer
por: Wang, Zhiyu, et al.
Publicado: (2013)

MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin
por: Wang, Zhiyu, et al.
Publicado: (2014)

Neoangiogenesis in prostate cancer
por: Łuczyńska, Elżbieta, et al.
Publicado: (2013)

Elevating VEGF-A and PDGF-BB secretion by salidroside enhances neoangiogenesis in diabetic hind-limb ischemia
por: Ariyanti, Agnes Dwi, et al.
Publicado: (2017)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
por: Liao, Xiaozhong, et al.
Publicado: (2020)

Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models
por: Coroniti, Roberta, et al.
Publicado: (2016)

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
por: Liao, Xiaozhong, et al.
Publicado: (2021)

Relationship between Chinese medicine dietary patterns and the incidence of breast cancer in Chinese women in Hong Kong: a retrospective cross-sectional survey
por: Zheng, Xiao, et al.
Publicado: (2017)

Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy
por: Wang, Zhiyu, et al.
Publicado: (2012)

Corrigendum: Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models
por: Coroniti, Roberta, et al.
Publicado: (2016)

Perspectives on the Role of Isoliquiritigenin in Cancer
por: Wang, Kai-Lee, et al.
Publicado: (2021)

VEGF-VEGFR Signals in Health and Disease
por: Shibuya, Masabumi
Publicado: (2014)

Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models
por: Lin, Po-Han, et al.
Publicado: (2020)

Coral-Derived Compound WA-25 Inhibits Angiogenesis by Attenuating the VEGF/VEGFR2 Signaling Pathway
por: Lin, Shih-Wei, et al.
Publicado: (2015)

Neoangiogenesis of gastric submucosa-invasive adenocarcinoma
por: Sasaki, Hanae, et al.
Publicado: (2018)

Novel role of Snail 1 in promoting tumor neoangiogenesis
por: Zhang, Yi-Kun, et al.
Publicado: (2019)

Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
por: Peng, Fu, et al.
Publicado: (2017)

Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice
por: Wu, Chi-Hao, et al.
Publicado: (2016)

The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer
por: Dziobek, Konrad, et al.
Publicado: (2019)

Isoliquiritigenin, a Chalcone Compound, Enhances Spontaneous Inhibitory Postsynaptic Response
por: Woo, Junsung, et al.
Publicado: (2014)

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
por: Fontanini, G., et al.
Publicado: (1997)

Targeting VEGF/VEGFR to Modulate Antitumor Immunity
por: Yang, Ju, et al.
Publicado: (2018)

Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth
por: Chen, Hsin-Yuan, et al.
Publicado: (2017)

Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
por: Liu, Guihong, et al.
Publicado: (2021)

Molecular structure‐function relationship of dietary polyphenols for inhibiting VEGF‐induced VEGFR‐2 activity
por: Cerezo, Ana B., et al.
Publicado: (2015)

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
por: Nascimento, Catarina, et al.
Publicado: (2021)

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer
por: Duffy, John P, et al.
Publicado: (2003)

Neoangiogenesis in Melanoma: An Issue in Biology and Systemic Treatment
por: Quaresmini, Davide, et al.
Publicado: (2020)

Author Correction: Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis
por: Peng, Fu, et al.
Publicado: (2023)

The inhibitory effect of isoliquiritigenin on human platelets in vitro
por: Wu, Yingying, et al.
Publicado: (2023)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome
por: Sjöström, S., et al.
Publicado: (2010)

Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
por: Yang, Gui-Li, et al.
Publicado: (2018)

The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy
por: Mabeta, Peace, et al.
Publicado: (2022)

Structure-Based Design of Peptides Targeting VEGF/VEGFRs
por: Di Stasi, Rossella, et al.
Publicado: (2023)

Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive Indolic Compounds
por: Cerezo, Ana B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3j5kkjpcejbjngv9iqr9utsir9